Randomised controlled trial to reduce morbidity of bronchiolitis in young children admitted to Royal Darwin hospital in the NT

Abstract

Background Bronchiolitis is the most common reason for hospital admission for infants globally(1). The use of antibiotics, in particular macrolides for treating bronchiolitis in non affluent settings remains controversial but potentially beneficial. In our region, readmission with lower respiratory illness in young children, particularly Indigenous children remains high.